Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1996-07-26
1999-10-26
Stucker, Jeffrey
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
424 932, 4242301, 4242311, 4242291, 435236, 435325, C12N 1500, C12N 704, A01N 6300, A61K 39245
Patent
active
059726660
ABSTRACT:
A vaccine is described which comprises an assembly-deficient herpesvirus. The mutant herpesvirus is capable of infecting and undergoing DNA replication in the cells of a susceptible mammal, but is defective in capsid assembly and formation of mature virion particles. The assembly-deficient herpesvirus is avirulent and capable of generating a protective immune response in a vaccinated mammal.
REFERENCES:
patent: 5384122 (1995-01-01), Cunningham et al.
Rixon F. et al. Insertion of DNA at a unique restriction enzyme site engineered for vector purposes into the genome of herpes simplex virus type I, J. Gen. Virol. 71:2931-2939, 1990.
Hippenmeyer Paul J
Luckow Verne A
Rankin Anne M
Bennett Dennis A.
Bulock Joseph W.
G. D. Searle & Co.
Park Hankyel T.
Stucker Jeffrey
LandOfFree
Assembly-deficient herpesvirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assembly-deficient herpesvirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assembly-deficient herpesvirus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-762618